Skip to content
Application 205871
- Type
- ANDA
- Sponsor
- SAGENT PHARMS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | FULVESTRANT | FULVESTRANT | INJECTABLE;INTRAMUSCULAR | 50MG/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 25021-462 | fulvestrant | fulvestrant | Sagent Pharmaceuticals | ANDA | Current |
| 25021-462 | fulvestrant | fulvestrant | Sagent Pharmaceuticals | ANDA | Current |
| 25021-462 | fulvestrant | fulvestrant | Sagent Pharmaceuticals | ANDA | Current |
| 25021-462 | fulvestrant | fulvestrant | Sagent Pharmaceuticals | ANDA | Current |
| 25021-462 | fulvestrant | fulvestrant | Sagent Pharmaceuticals | ANDA | Current |
| 68001-424 | fulvestrant | fulvestrant | BluePoint Laboratories | ANDA | Current |
| 68001-424 | fulvestrant | fulvestrant | BluePoint Laboratories | ANDA | Current |
| 68001-424 | fulvestrant | fulvestrant | BluePoint Laboratories | ANDA | Current |
| 68001-424 | fulvestrant | fulvestrant | BluePoint Laboratories | ANDA | Current |
| 68001-424 | fulvestrant | fulvestrant | BluePoint Laboratories | ANDA | Current |